Group Menu -> Home Search Careers Investors Press Contact Us Eurofins >> COVID-19-Response >> Latest News Latest News Eurofins Technologies announces launch of RT PCR kits for rapid detection of SARS-CoV-2 variant B.1.1529 Eurofins responds to increased demand for COVID-19 testing at schools with cost-effective testing programmes for the educational sector Eurofins expands its network of COVID-19 testing centers, including airports, ports, train stations and drive-through testing centers, to enable convenient and safe international travel Eurofins and Rite Aid launch an over-the-counter, FDA-authorised, at-home COVID-19 PCR test in all Rite Aid locations in the U.S. Eurofins Viracor Invests in Innovation with the Launch of Coronavirus (COVID-19) SARS-CoV-2 inSIGHT™ T Cell Immunity Testing Eurofins opens Europe-wide COVID-19 testing centre network to facilitate summer travel Eurofins launches a new multiplex PCR assay for rapid detection of the B.1.617 “India” SARS-CoV-2 variant Eurofins Awarded U.S. Government Agreement to Expand National COVID-19 Testing Eurofins expands its global sequencing and mutation-specific PCR capabilities to detect COVID-19 Variants of Concern and of Interest Eurofins’ empowerDX at-home COVID-19 testing kit receives EUA for children three years and older Eurofins at the forefront of innovation with new developments for detection and identification of emerging COVID-19 variants of concern Eurofins supports reopening of UK travel with launch of affordable day 2 & 8 testing services Eurofins subsidiary empowerDX and Uber team up, offer at-home COVID-19 testing kits via on-demand delivery in more than two dozen U.S. cities Eurofins Covid Testing Services Ltd (ECTS) supports reopening UK travel by making PCR testing affordable for all Eurofins Technologies launches an enhanced variant of concern-discriminating PCR test including the South African variant (B.1.351) Eurofins launches empowerDX COVID-19 home collection kit on Amazon Eurofins Announces the launch of an At-Home COVID-19 PCR Test kit available direct to consumers, without prescription Eurofins Forensics adds significant COVID-19 testing capacity to the UK with home testing roll-out Eurofins donates 100,000 fast PCR tests to detect SARS-CoV-2 variants B.1.1.7 (ex. UK), B.1.351 (ex. South Africa) and B1.1.248 (ex. Brazil) to hospitals around the world Eurofins Scientific Announces Acquisition of Beacon Discovery, Substantially Expanding Its Integrated Drug Discovery Capabilities and Expertise Eurofins adds virus variant distinction to its SARS-CoV-2 monitoring solution for wastewater, food and environmental surfaces Eurofins Launches New ultra-fast Extraction-free RT-PCR Method and Upgrades its RT-PCR Assay for Use with Pharynx Gargle and Saliva Sample Matrices Eurofins Launches Quantitative Antibody Test to Measure Immune Response to COVID-19 and Vaccines Eurofins launches new tests and massive capacity for detecting and monitoring new variants of SARS-CoV-2 Eurofins GeneScan Technologies announces AOAC PTM accreditation for the VIRSeek SARS-CoV-2 detection workflow on environmental surfaces under the AOAC SARS-CoV-2 Emergency Response Validation Program Eurofins Bioanalytical Services launches Surrogate Virus Neutralizing antibody detection assays against the SARS-CoV-2 (COVID-19) Eurofins Genomics launches cost-effective SARS-CoV-2 full-length viral genome sequencing services essential in the identification of viral mutations Eurofins launches COVID-19 PCR tests with at-home self-sampling options in Europe and donates sequencing capacity to identify VUI-2020-12/01 strain reported to spread faster in the UK Eurofins launches a rapid SARS-CoV-2 antigen test and a RT-PCR test in a self-sampled, gargling format Eurofins U.S. Clinical Diagnostic Laboratories Partner with Insurance Providers to Cover FDA-Authorized At-Home COVID-19 Test Eurofins launches sensitive, fast and cost-effective high throughput SARS-CoV-2 test kits for widely available Sanger sequencing equipment Eurofins U.S. Clinical Diagnostics Network Receives EUA Approval of At Home COVID-19 Test At Home COVID-19 Nasal PCR Test is easy to use and painless Eurofins Biomnis to create additional capacity of 15,000 tests per day carried out within 24 hours to help combat the second wave of the COVID-19 pandemic Eurofins launches Europe’s first validated test method to evaluate filtration capacity of masks for SARS-CoV-2 Eurofins Diatherix launches Flu Plus to identify SARS-CoV-2 and five additional viruses Eurofins Technologies Serological Assays Demonstrate Ability to Identify Neutralizing Antibodies Eurofins providing COVID-19 analytical testing and services for Pennsylvania Long Term Care Facilities and vulnerable population citizens Eurofins Clinical Diagnostics Launches Lower Cost Highly Accurate COVID-19 PCR Test Eurofins Technologies launches reagents for automated extraction of genomic SARS-CoV-2 RNA from clinical swab samples Eurofins publishes robust method to analyse SARS-CoV-2 in wastewater samples, providing early warning of potential COVID-19 outbreak at a given site Eurofins publishes method for early detection of asymptomatic SARS-CoV-2 virus spreaders, that does not require human PCR clinical testing Eurofins Technologies launches rapid point-of-care testing devices that identify exposure to COVID-19 in only 10 minutes Eurofins U.S. Clinical Diagnostics Network Announces Launch of Highly Accurate, Cost Effective, COVID-19 Pooled PCR Test Eurofins Technologies launches total antibody (IgG, IgA and IgM) detection ELISA assays to aid the rapid identification of persons who have been exposed to SARS-CoV-2 (COVID-19) Eurofins Launches Eurofins SAFER@WORK™: a Comprehensive Suite of Risk-Based COVID-19 Safety Solutions for Businesses Eurofins Technologies launches multiplex Real-Time PCR assay for SARS-CoV-2 (coronavirus) pathogen detection Eurofins scientists develop multiple new solutions to support the world’s fight against the COVID-19 pandemic – ramping up production to enable over 20 million patients tests per month by end May 2020 Activity shows strong resilience in Q1 2020 Eurofins Medical Device Testing commitment to support the safety and efficacy of devices used in the COVID-19 Crisis Response Eurofins BioPharma Product Testing delivers vital COVID-19 testing for all drug modalities and supply chains Eurofins Technologies launches multiple CE-IVD marked serologic products for the detection of antibodies in patients who have been exposed to SARS-CoV-2 (COVID-19) Eurofins Genomics launches “SARS-CoV-2 Full-length Genome Sequencing” service to support researchers globally in their fight against the COVID-19 pandemic and outbreak source tracing Eurofins Genomics U.S. launches new SARS-CoV-2 plasmid DNA controls and increases its capacity to produce probes and primers, all of which being key components of SARS-CoV-2 RT-PCR testing Eurofins Discovery Supports Critical COVID-19 Drug Discovery Research with Products and Accelerated Drug Discovery Services Eurofins Technologies launches multiple new products for the serologic detection of antibodies in patients who have been exposed to COVID-19 Gold Standard Diagnostics COVID-19 Antibody Tests Now Available Viracor Eurofins Receives Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) for its SARS-CoV-2 RT-PCR laboratory-developed test (LDT) The National Kidney Registry and Viracor Eurofins Announce Coronavirus Antibody Testing for Donors and Recipients Eurofins Scientific Offers a full range of Testing services for Personal Protective Equipment (PPEs) and Medical Devices used in the fight against the COVID pandemic Eurofins’ U.S. Clinical Diagnostics Network Launches Coronavirus (COVID-19) Antibody Testing Announcing Labs@HOME, an In-Home Mobile Phlebotomy Blood Draw Service for Post-Transplant Patient Testing During COVID-19 Eurofins Technologies launches testing solutions for the detection of SARS-CoV-2 on environmental surfaces Eurofins Scientific Supports Healthcare Authorities in Europe, the U.S.A. and Brazil in their Fight against the COVID-19 Pandemic with Additional Testing Options and Fast Growing Capacity Eurofins Transplant Genomics and Viracor Will Partner to Offer Remote Sample Collection Options to Support Care for Kidney Transplant Recipients During COVID-19 Outbreak Diatherix Eurofins launches SARS-CoV-2 virus identification for the COVID-19 respiratory infection Eurofins Scientific Supports SARS-CoV-2 Analyses needs in the U.S.A. and in Europe with Multiple Testing Options Viracor Eurofins Launches Coronavirus SARS-CoV-2 RT-PCR Test with Same Day Results (12-18 Hours) Homepage | Search | Careers | Press | Contact Us | Investors Sitemap | Cookie Notice | Terms and Conditions | Eurofins Global Cookie Preferences © Eurofins Scientific 2021 Last updated: Monday, November 22, 2021 About Cookies on This Site By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. Cookie Policy Accept All Cookies Adjust Preferences